OBJECTIVE: To develop a clinical risk prediction tool to identify patients most likely to experience long-term clinically meaningful functional improvement following total hip arthroplasty (THA). METHODS: We studied 282 patients from 2 health districts in England (Portsmouth and North Staffordshire) who were ≥45 years of age and undergoing THA for primary osteoarthritis. Baseline data on age, sex, comorbidity, body mass index (BMI), functional status (Short Form 36 [SF-36]), and preoperative radiographic severity were collected by interview and examination. The outcome was a clinically significant (30-point) improvement in SF-36 physical function score assessed ~8 years after THA. Logistic regression modeling was used to identify predictors of functional improvement. RESULTS: Improvement in physical function was less likely in patients with better preoperative functioning (odds ratio [OR] 0.73 [95% confidence interval (95% CI) 0.60, 0.89]), older people (OR 0.94 [95% CI 0.90, 0.98]), women (OR 0.37 [95% CI 0.19, 0.72]), those with a previous hip injury (OR 0.14 [95% CI 0.03, 0.74]), and those with a greater number of painful joint sites (OR 0.61 [95% CI 0.46, 0.80]). Patients with worse radiographic grades were most likely to improve (OR 2.15 [95% CI 1.17, 3.93]). We found no influence of BMI or patient comorbidity on functional outcome. Predictors of good outcomes were the same as those of bad outcomes, acting in the opposite direction. A clinical risk prediction tool was developed to identify patients who are most likely to receive functional improvement following THA. CONCLUSION: This prediction tool has the potential to inform health care professionals and patients about functional improvement following THA (as distinct from driving rationing or commissioning decisions regarding who should have surgery); it requires introduction into clinical practice under research conditions to investigate its impact on decisions made by patients and clinicians.
OBJECTIVE: To develop a clinical risk prediction tool to identify patients most likely to experience long-term clinically meaningful functional improvement following total hip arthroplasty (THA). METHODS: We studied 282 patients from 2 health districts in England (Portsmouth and North Staffordshire) who were ≥45 years of age and undergoing THA for primary osteoarthritis. Baseline data on age, sex, comorbidity, body mass index (BMI), functional status (Short Form 36 [SF-36]), and preoperative radiographic severity were collected by interview and examination. The outcome was a clinically significant (30-point) improvement in SF-36 physical function score assessed ~8 years after THA. Logistic regression modeling was used to identify predictors of functional improvement. RESULTS: Improvement in physical function was less likely in patients with better preoperative functioning (odds ratio [OR] 0.73 [95% confidence interval (95% CI) 0.60, 0.89]), older people (OR 0.94 [95% CI 0.90, 0.98]), women (OR 0.37 [95% CI 0.19, 0.72]), those with a previous hip injury (OR 0.14 [95% CI 0.03, 0.74]), and those with a greater number of painful joint sites (OR 0.61 [95% CI 0.46, 0.80]). Patients with worse radiographic grades were most likely to improve (OR 2.15 [95% CI 1.17, 3.93]). We found no influence of BMI or patient comorbidity on functional outcome. Predictors of good outcomes were the same as those of bad outcomes, acting in the opposite direction. A clinical risk prediction tool was developed to identify patients who are most likely to receive functional improvement following THA. CONCLUSION: This prediction tool has the potential to inform health care professionals and patients about functional improvement following THA (as distinct from driving rationing or commissioning decisions regarding who should have surgery); it requires introduction into clinical practice under research conditions to investigate its impact on decisions made by patients and clinicians.
Authors: Pakdee Rojanasopondist; Vincent P Galea; James W Connelly; Sean J Matuszak; Ola Rolfson; Charles R Bragdon; Henrik Malchau Journal: Clin Orthop Relat Res Date: 2019-06 Impact factor: 4.176
Authors: Cesar Garriga; Maria T Sánchez-Santos; Andrew Judge; Deborah Hart; Tim Spector; Cyrus Cooper; Nigel K Arden Journal: Arthritis Care Res (Hoboken) Date: 2020-01 Impact factor: 4.794
Authors: K-P Günther; E Haase; T Lange; C Kopkow; J Schmitt; C Jeszenszky; F Balck; J Lützner; A Hartmann; M Lippmann Journal: Orthopade Date: 2015-07 Impact factor: 1.087
Authors: Hylton B Menz; Maria Auhl; Jade M Tan; Pazit Levinger; Edward Roddy; Shannon E Munteanu Journal: BMC Musculoskelet Disord Date: 2017-05-12 Impact factor: 2.362
Authors: Stefanie N Hofstede; Maaike G J Gademan; Theo Stijnen; Rob G H H Nelissen; Perla J Marang-van de Mheen Journal: BMC Musculoskelet Disord Date: 2018-03-02 Impact factor: 2.362
Authors: Andy Judge; Nigel K Arden; Rajbir N Batra; Geraint Thomas; David Beard; M Kassim Javaid; Cyrus Cooper; David Murray Journal: BMJ Open Date: 2013-03-01 Impact factor: 2.692
Authors: J Christiaan Keurentjes; Marta Fiocco; Cynthia So-Osman; Ron Onstenk; Ankie W M M Koopman-Van Gemert; Ruud G Pöll; Herman M Kroon; Thea P M Vliet Vlieland; Rob G Nelissen Journal: PLoS One Date: 2013-04-03 Impact factor: 3.240
Authors: Stefanie N Hofstede; Maaike G J Gademan; Thea P M Vliet Vlieland; Rob G H H Nelissen; Perla J Marang-van de Mheen Journal: BMC Musculoskelet Disord Date: 2016-05-17 Impact factor: 2.362